openPR Logo
Press release

Inflammation and Pain Post Cataract Surgery Treatment Market 2034: FDA Approvals, Clinical Trials, Pipeline, Prevalence and Companies by DelveInsight | Ocular Therapeutix, Alcon, Eyenovia, VivaVision Biotech, Oculis

07-11-2024 07:21 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Inflammation and Pain Post Cataract Surgery Market

Inflammation and Pain Post Cataract Surgery Market

(Albany, USA) DelveInsight's "Inflammation and Pain Post Cataract Surgery Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Inflammation and Pain Post Cataract Surgery, historical and forecasted epidemiology as well as the Inflammation and Pain Post Cataract Surgery market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Inflammation and Pain Post Cataract Surgery market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Inflammation and Pain Post Cataract Surgery Market Forecast
https://www.delveinsight.com/sample-request/inflammation-and-pain-post-cataract-surgery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Some of the key facts of the Inflammation and Pain Post Cataract Surgery Market Report:
• The Inflammation and Pain Post Cataract Surgery market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• According to DelveInsight's analysis, approximately 20 million Americans aged 40 and older have cataracts in one or both eyes, and around 6 million have undergone lens removal surgery. Chronic or recurrent inflammation, including cystoid macular edema, affects about 0.1% to 2% of patients following routine cataract surgery.
• The market for managing inflammation and pain following cataract surgery is currently led by companies such as Ocular Therapeutix, Alcon, and Eyenovia, offering products like DEXTENZA, INVELTYS, and APP13007.
• To drive market growth in the coming years, companies such as VivaVision Biotech and Oculis are developing assets like VVN461 and OCS-01 for managing inflammation and pain after cataract surgery.
• According to a 2019 analysis, 2,200 cataract surgeries were performed in the US, with approximately 40 eyes experiencing post-operative iritis that persisted for more than one month.
• Cataract surgery is the most frequently performed elective surgical procedure in the UK, with approximately 330,000 operations conducted annually in England alone.
• Key Inflammation and Pain Post Cataract Surgery Companies: Ocular Therapeutix, Alcon, Eyenovia, VivaVision Biotech, Oculis, and others
• Key Inflammation and Pain Post Cataract Surgery Therapies: DEXTENZA (dexamethasone), INVELTYS (loteprednol etabonate ophthalmic suspension), APP13007 (clobetasol propionate), VVN461, OCS-01. Dexamethasone Ophthalmic Suspension, and others
• The Inflammation and Pain Post Cataract Surgery market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Inflammation and Pain Post Cataract Surgery pipeline products will significantly revolutionize the Inflammation and Pain Post Cataract Surgery market dynamics.

Inflammation and Pain Post Cataract Surgery Overview
Cataract surgery is a common and generally safe procedure used to restore vision in patients with clouded lenses. However, like any surgical procedure, it can lead to post-operative complications, the most common being inflammation and pain.

Get a Free sample for the Inflammation and Pain Post Cataract Surgery Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/inflammation-and-pain-post-cataract-surgery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Inflammation and Pain Post Cataract Surgery Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Inflammation and Pain Post Cataract Surgery Epidemiology Segmentation:
The Inflammation and Pain Post Cataract Surgery market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Inflammation and Pain Post Cataract Surgery
• Prevalent Cases of Inflammation and Pain Post Cataract Surgery by severity
• Gender-specific Prevalence of Inflammation and Pain Post Cataract Surgery
• Diagnosed Cases of Episodic and Chronic Inflammation and Pain Post Cataract Surgery

Download the report to understand which factors are driving Inflammation and Pain Post Cataract Surgery epidemiology trends @ Inflammation and Pain Post Cataract Surgery Epidemiology Forecast
https://www.delveinsight.com/sample-request/inflammation-and-pain-post-cataract-surgery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Inflammation and Pain Post Cataract Surgery Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Inflammation and Pain Post Cataract Surgery market or expected to get launched during the study period. The analysis covers Inflammation and Pain Post Cataract Surgery market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Inflammation and Pain Post Cataract Surgery Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Inflammation and Pain Post Cataract Surgery Therapies and Key Companies
• DEXTENZA (dexamethasone): Ocular Therapeutix
• INVELTYS (loteprednol etabonate ophthalmic suspension): Alcon
• APP13007 (clobetasol propionate): Eyenovia
• VVN461: VivaVision Biotech
• OCS-01: Oculis
• Dexamethasone Ophthalmic Suspension: Oculis
• Clobetasol Propionate

Discover more about therapies set to grab major Inflammation and Pain Post Cataract Surgery market share @ Inflammation and Pain Post Cataract Surgery Treatment Landscape
https://www.delveinsight.com/sample-request/inflammation-and-pain-post-cataract-surgery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Inflammation and Pain Post Cataract Surgery Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Inflammation and Pain Post Cataract Surgery Companies: Ocular Therapeutix, Alcon, Eyenovia, VivaVision Biotech, Oculis, and others
• Key Inflammation and Pain Post Cataract Surgery Therapies: DEXTENZA (dexamethasone), INVELTYS (loteprednol etabonate ophthalmic suspension), APP13007 (clobetasol propionate), VVN461, OCS-01. Dexamethasone Ophthalmic Suspension, and others
• Inflammation and Pain Post Cataract Surgery Therapeutic Assessment: Inflammation and Pain Post Cataract Surgery current marketed and Inflammation and Pain Post Cataract Surgery emerging therapies
• Inflammation and Pain Post Cataract Surgery Market Dynamics: Inflammation and Pain Post Cataract Surgery market drivers and Inflammation and Pain Post Cataract Surgery market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Inflammation and Pain Post Cataract Surgery Unmet Needs, KOL's views, Analyst's views, Inflammation and Pain Post Cataract Surgery Market Access and Reimbursement

To know more about Inflammation and Pain Post Cataract Surgery companies working in the treatment market, visit @ Inflammation and Pain Post Cataract Surgery Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/inflammation-and-pain-post-cataract-surgery-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Inflammation and Pain Post Cataract Surgery Market Report Introduction
2. Executive Summary for Inflammation and Pain Post Cataract Surgery
3. SWOT analysis of Inflammation and Pain Post Cataract Surgery
4. Inflammation and Pain Post Cataract Surgery Patient Share (%) Overview at a Glance
5. Inflammation and Pain Post Cataract Surgery Market Overview at a Glance
6. Inflammation and Pain Post Cataract Surgery Disease Background and Overview
7. Inflammation and Pain Post Cataract Surgery Epidemiology and Patient Population
8. Country-Specific Patient Population of Inflammation and Pain Post Cataract Surgery
9. Inflammation and Pain Post Cataract Surgery Current Treatment and Medical Practices
10. Inflammation and Pain Post Cataract Surgery Unmet Needs
11. Inflammation and Pain Post Cataract Surgery Emerging Therapies
12. Inflammation and Pain Post Cataract Surgery Market Outlook
13. Country-Wise Inflammation and Pain Post Cataract Surgery Market Analysis (2020-2034)
14. Inflammation and Pain Post Cataract Surgery Market Access and Reimbursement of Therapies
15. Inflammation and Pain Post Cataract Surgery Market Drivers
16. Inflammation and Pain Post Cataract Surgery Market Barriers
17. Inflammation and Pain Post Cataract Surgery Appendix
18. Inflammation and Pain Post Cataract Surgery Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Trending Reports:
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Biochips Market: https://www.delveinsight.com/report-store/biochips-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-a1atd-market
• Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/rheumatoid-arthritis-ra-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Hemophilia B Market: https://www.delveinsight.com/report-store/hemophilia-b-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Pain Management Devices Market: https://www.delveinsight.com/report-store/pain-management-devices-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Inflammation and Pain Post Cataract Surgery Treatment Market 2034: FDA Approvals, Clinical Trials, Pipeline, Prevalence and Companies by DelveInsight | Ocular Therapeutix, Alcon, Eyenovia, VivaVision Biotech, Oculis here

News-ID: 3577405 • Views:

More Releases from DelveInsight Business Research

Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market. The Spinocerebellar
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics. DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,
Myocardial Infarction Market Positioned for Accelerated Development Through 2034, DelveInsight Finds
Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the

All 5 Releases


More Releases for Cataract

Cataract Pipeline: Emerging Non-Surgical Solutions and Leading Companies Shaping …
The therapeutic landscape for Cataract, the leading cause of blindness globally, is undergoing a paradigm shift as researchers and biopharmaceutical companies explore non-surgical and disease-modifying alternatives to conventional cataract extraction surgery. Advances in molecular biology, oxidative stress modulation, and crystallin protein stabilization have opened new avenues for pharmacological intervention. Companies like Nacuity Pharmaceuticals, CGeneTech, and Plex Pharmaceuticals are pioneering efforts to develop novel agents aimed at delaying, halting, or reversing
Cataract Surgery Devices Market - Innovation Meets Precision: Elevate Cataract S …
Newark, New Castle, USA: The "Cataract Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cataract Surgery Devices Market: https://www.growthplusreports.com/report/cataract-surgery-devices-market/7846 This latest report researches the industry structure,
Intraocular Lens Implants for Cataract Market is Driven by the Increasing Incide …
The proposed Intraocular Lens Implants for Cataract Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Intraocular Lens Implants for Cataract Market
Potential Opportunities of Cataract Surgical Devices Market
The global cataract surgical devices market size is projected to reach USD 9.98 billion by the end of 2026. The high prevalence of cataract disorders will open up a huge potential for market growth. According to a report published by Fortune Business Insights, titled "Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user
Cataract Devices Market Forecast by 2015: QY Research, Inc.
According to a new report published by QY Research, Titled “Global Cataract Devices Market Professional Survey Report 2018,” by Company Profile Deals Type, Funding, Clinical Trials Insight, Regulatory Landscape & Recent Development has been featured on QY Research. Cataract Surgery is the removal of the eye’s clouded natural lens, and replacing it with an artificial lens that helps restore vision to the eye. Without removing the cataract surgically, most patients with
Cataract Surgery Devices Market Opportunity Analysis, 2018-2026
Cataract surgery devices are used during the surgical procedures to treat cataract, which is an eye disorder that causes clouding of the lens leading to defects in vision. Cataract is one of the most widespread disease causing blindness and it reduces vision ability. Cataract is often encountered to develop slowly and affect either one or both the eyes. Although cataract does not interfere with the eyesight in the early stages, it